ReviewAnnals of hematology2019

Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma.

Tiantian Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.